Epipen 0.3mg / 0.3ml. 0.15mg / 0.3ml Injection

    Epipen 0.3mg / 0.3ml. 0.15mg / 0.3ml Injection

    S4
    PDF Leaflet Revision Date: 07 July 2006

    API: Adrenaline | Company: Mylan

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Emergency treatment of severe anaphylactic reactions.

    Dosage (summary)

    0.3 ml for adults/children >45 kg; 0.15 ml for children <45 kg.

    Special Populations

    • Hyperthyroidism
    • Ischaemic heart disease
    • Arrhythmia
    • Tachycardia
    • Hypertension
    • Diabetes mellitus

    Key Drug Interactions

    • Monoamine oxidase inhibitors
    • Alpha and beta blockers

    Contraindications

    • Sensitivity to ingredients
    • Sensitivity to sulphites

    Common side effects

    • Fear
    • Anxiety
    • Tremors
    • Tachycardia
    • Nausea

    Counselling Points

    • Administer immediately for life-threatening reactions
    • Single use only
    • Consult doctor after use

    Serious warnings

    • Check solution for discoloration every 14 days
    • Accidental injection requires immediate hospitalization
    Important Disclaimer

    The Epipen 0.3mg / 0.3ml. 0.15mg / 0.3ml Injection professional information leaflet below is the property of Mylan and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn